These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27575332)

  • 41. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical application of amplicon-based next-generation sequencing in cancer.
    Chang F; Li MM
    Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing.
    Mu W; Lu HM; Chen J; Li S; Elliott AM
    J Mol Diagn; 2016 Nov; 18(6):923-932. PubMed ID: 27720647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of clinical analytical sensitivity and specificity of next-generation sequencing for detection of simple and complex mutations.
    Chin EL; da Silva C; Hegde M
    BMC Genet; 2013 Feb; 14():6. PubMed ID: 23418865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tilling by sequencing.
    Tsai H; Ngo K; Lieberman M; Missirian V; Comai L
    Methods Mol Biol; 2015; 1284():359-80. PubMed ID: 25757782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeted ultradeep next-generation sequencing as a method for KIT D816V mutation analysis in mastocytosis.
    Kristensen T; Broesby-Olsen S; Vestergaard H; Bindslev-Jensen C; Møller MB;
    Eur J Haematol; 2016 Apr; 96(4):381-8. PubMed ID: 26095448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a robust DNA quality and quantity assessment qPCR assay for targeted next-generation sequencing library preparation.
    Dang J; Mendez P; Lee S; Kim JW; Yoon JH; Kim TW; Sailey CJ; Jablons DM; Kim IJ
    Int J Oncol; 2016 Oct; 49(4):1755-65. PubMed ID: 27511764
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-p.V600E BRAF Mutations Are Common Using a More Sensitive and Broad Detection Tool.
    Carter J; Tseng LH; Zheng G; Dudley J; Illei P; Gocke CD; Eshleman JR; Lin MT
    Am J Clin Pathol; 2015 Oct; 144(4):620-8. PubMed ID: 26386083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progress and potential of RAS mutation detection for diagnostics and companion diagnostics.
    Cree IA
    Expert Rev Mol Diagn; 2016 Oct; 16(10):1067-1072. PubMed ID: 27494709
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation of a yeast functional assay for p53 mutations using clonal sequencing.
    Iggo R; Rudewicz J; Monceau E; Sevenet N; Bergh J; Sjoblom T; Bonnefoi H
    J Pathol; 2013 Dec; 231(4):441-8. PubMed ID: 23897043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utility of different massive parallel sequencing platforms for mutation profiling in clinical samples and identification of pitfalls using FFPE tissue.
    Fassunke J; Haller F; Hebele S; Moskalev EA; Penzel R; Pfarr N; Merkelbach-Bruse S; Endris V
    Int J Mol Med; 2015 Nov; 36(5):1233-43. PubMed ID: 26352389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A rapid NGS strategy for comprehensive molecular diagnosis of Birt-Hogg-Dubé syndrome in patients with primary spontaneous pneumothorax.
    Zhang X; Ma D; Zou W; Ding Y; Zhu C; Min H; Zhang B; Wang W; Chen B; Ye M; Cai M; Pan Y; Cao L; Wan Y; Jin Y; Gao Q; Yi L
    Respir Res; 2016 May; 17(1):64. PubMed ID: 27229674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.
    Hovelson DH; McDaniel AS; Cani AK; Johnson B; Rhodes K; Williams PD; Bandla S; Bien G; Choppa P; Hyland F; Gottimukkala R; Liu G; Manivannan M; Schageman J; Ballesteros-Villagrana E; Grasso CS; Quist MJ; Yadati V; Amin A; Siddiqui J; Betz BL; Knudsen KE; Cooney KA; Feng FY; Roh MH; Nelson PS; Liu CJ; Beer DG; Wyngaard P; Chinnaiyan AM; Sadis S; Rhodes DR; Tomlins SA
    Neoplasia; 2015 Apr; 17(4):385-99. PubMed ID: 25925381
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A straightforward assay to evaluate DNA integrity and optimize next-generation sequencing for clinical diagnosis in oncology.
    Bettoni F; Koyama FC; de Avelar Carpinetti P; Galante PAF; Camargo AA; Asprino PF
    Exp Mol Pathol; 2017 Dec; 103(3):294-299. PubMed ID: 29175301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
    Andersson C; Fagman H; Hansson M; Enlund F
    Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of capillary electrophoresis for DNA polymorphism analysis.
    Mitchelson KR
    Mol Biotechnol; 2003 May; 24(1):41-68. PubMed ID: 12721495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-throughput sequencing in mutation detection: A new generation of genotoxicity tests?
    Maslov AY; Quispe-Tintaya W; Gorbacheva T; White RR; Vijg J
    Mutat Res; 2015 Jun; 776():136-43. PubMed ID: 25934519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic validation of a familial hypercholesterolaemia cohort provides a model for using targeted next generation DNA sequencing in the clinical setting.
    Hinchcliffe M; Le H; Fimmel A; Molloy L; Freeman L; Sullivan D; Trent RJ
    Pathology; 2014 Jan; 46(1):60-8. PubMed ID: 24300713
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of the GeneReader NGS System in a clinical pathology laboratory: a comparative study.
    Koitzsch U; Heydt C; Attig H; Immerschitt I; Merkelbach-Bruse S; Fammartino A; Büttner RH; Kong Y; Odenthal M
    J Clin Pathol; 2017 Aug; 70(8):725-728. PubMed ID: 28400467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeted sequencing of both DNA strands barcoded and captured individually by RNA probes to identify genome-wide ultra-rare mutations.
    Wang Q; Wang X; Tang PS; O'leary GM; Zhang M
    Sci Rep; 2017 Jun; 7(1):3356. PubMed ID: 28611392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.